PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

86 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Ashar, F.N.* et al.: A comprehensive evaluation of the genetic architecture of sudden cardiac arrest. Eur. Heart J. 39, 3961-3969 (2018)
22.
Elhadad, M.A. et al.: Using the plasma proteome to decipher metabolic syndrome pathophysiology and discover a diagnostic biomarker panel. Eur. Heart J. 39, 998-998 (2018)
23.
Faber, J.* et al.: Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: Data from the German CVSS-study. Eur. Heart J. 39, 1555-1562 (2018)
24.
My, I.* et al.: Primary cilium-autophagy-cell cycle axis defects impair cardiac progenitor specification in hypoplastic left heart syndrome. Eur. Heart J. 39, 390-391 (2018)
25.
Steinbeck, G.* et al.: Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: A nationwide in-hospital analysis of administrative data for Germany in 2014. Eur. Heart J. 39, 4020-4029 (2018)
26.
Tomas, L.* et al.: Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques. Eur. Heart J. 39, 2301-2310 (2018)
27.
Brunner, S.* et al.: Alcohol consumption, sinus tachycardia, and cardiac arrhythmias at the Munich Octoberfest: Results from the Munich Beer Related Electrocardiogram Workup Study (MunichBREW). Eur. Heart J. 38, 2100-2106 (2017)
28.
Coassin, S.* et al.: A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction. Eur. Heart J. 38, 1823-1831 (2017)
29.
Fuks, K.B.* et al.: Long-term exposure to ambient air pollution and traffic noise and incident hypertension in seven cohorts of the European study of cohorts for air pollution effects (ESCAPE). Eur. Heart J. 38, 983-990 (2017)
30.
Waldeyer, C.* et al.: Lipoprotein(a) and the risk of cardiovascular disease in the European population: Results from the BiomarCaRE consortium. Eur. Heart J. 38, 2490-2498 (2017)
31.
Zewinger, S.* et al.: Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. Eur. Heart J. 38, 1597-1607 (2017)
32.
EUGenMed et al.: Gender in cardiovascular diseases: Impact on clinical manifestations, management, and outcomes. Eur. Heart J. 37, 24-34 (2016)
33.
Blankenberg, S.* et al.: Troponin I and cardiovascular risk prediction in the general population: The BiomarCaRE consortium. Eur. Heart J. 37, 2428-2437 (2016)
34.
Houssaini, A. et al.: Selective TSC1 deletion in smooth muscle activates mTOR signaling and induces pulmonary hypertension. Eur. Heart J. 37, 568-568 (2016)
35.
Itoh, H.* et al.: The genetics underlying acquired long QT syndrome: Impact for genetic screening. Eur. Heart J. 37, 1456-1464 (2016)
36.
Lorbeer, R.* et al.: Association of MRI derived hepatic fat fraction with blood pressure in a population-based sample. Eur. Heart J. 37, 417-417 (2016)
37.
Makarova, N.* et al.: Troponin I and cardiovascular risk prediction in the general population. Eur. Heart J. 37, 46-47 (2016)
38.
de Las Heras Gala, T. et al.: Overestimation of incident ASCVD events by the ACC/AHA risk score in the German population: The KORA and the Heinz Nixdorf Recall Studies. Eur. Heart J. 36, 711 (2015)
39.
Hernesniemi, J.A.* et al.: Predicting sudden cardiac death using common genetic risk variants for coronary artery disease. Eur. Heart J. 36, 1669-1675 (2015)
40.
Holmes, M.V.* et al.: Mendelian randomization of blood lipids for coronary heart disease. Eur. Heart J. 36, 539-550 (2015)